References
- Darken MA. Absorption and transport of fluorescent brighten-ers by microorganisms. Appl Microbiol 1962; 10: 387–393.
- Hageage GJ, Harrington JB. Use of calcofluor white in clinical mycology. Lab Med 1984; 15: 109–112.
- Hollander H, Keilig W, Bauer J, Rothemund E A reliable fluorescent stain for fungi in tissue sections and clinical speci-mens. Mycopathologia 1984; 88: 131–134.
- Monheit JE, Cowan DF, Moore DG. Rapid detection of fungi in tissues using cakofluor white and fluorescence microscopy. Arch Pathol Lab Med 1984; 108: 616–618.
- Maeda H, Ishida N. Specificity of binding of hexopyranosyl polysaccharides with fluorescent brightener. J Biochem 1967; 62: 276–278.
- Wood PJ, Fulcher RG. A basis for specific detection and histochemistry of polysaccharides. J Histochem Cytochem 1983; 31: 823–826.
- Hector RF, Braun PC, Hart if, Kamarck ME. The use of flow cytometry to monitor chitin synthesis in regenerating proto-plasts of Candida albicans. J Med Vet Mycol 1990; 28: 51–57.
- Koch HH, Pimsler M. Evaluation of Uvitex 2B: a nonspecific fluorescent stain for detection and identifying fungi and algae in tissue. Lab Med 1987; 18: 603–606.
- Wachsmuth ED. A comparison of the highly selective fluores-cence staining of fungi in tissue sections with Uvitex 2B and Calcofluor white M2R. Histochem J 1988; 20: 215–221.
- Klaschka F. Zur Diskussion toxikologischer Eigenschaften von optischen Aufhellern (Discussing the toxicological characteris-tics of whitening agents). Detmatosen 1994; 42: 66–70.
- Snyder FH, Opdyke DL, Rubenkoenig HL. Toxicologic studies on brighteners. Toxicol Appl Pharmacol 1963; 5: 176–183.
- Keplinger ML, Fancher OE, Lyman FL, Calandra JC. Toxico-logic studies of four fluorescent whitening agents. Toxicol Appl Pharmacol 1974; 27: 494–506.
- Resnitenko AK, Vosilenko NM, Mugikowski GL, Kras-noruzkaja EP. Toxicity of Belofor S.P.SCII. Gig Sanitar (Hyg Sanitat) 1984; 49 (1): 87–88.
- Reichard U, Biittner S, Fiffert H, Staib F, Riichel R. Purifica-tion and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol 1990; 33: 243–251.
- Ammon A, Rumpf KW, Hommerich CP, Behrens-Baumann W, Riichel R. Rhinozerebrale Mucor-Mycose unter Deferox-amin-Therapie (Rhinocerebral mucormycosis during deferox-amine treatment). Dtsch med Wschr 1992; 117: 1434–1438.
- Dixon DM, Polak A, Walsh TJ. Fungus dose-dependent pri-mary pulmonary aspergillosis in immunosuppressekl mice. Infect unman 1989; 57: 1452–1456.
- Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia: Lea & Febiger, 1992.
- Bernard A, Caillot D, Couaillier JF, Casasnovas 0, Guy H, Favre JP. Surgical management of invasive pulmonary asper-gillosis in neutropenic patients. Ann Thorac Surg 1997; 64: 1441–1447.
- Kern W, Braess J, Bertz H, et al. Chronic systemic aspergillosis in a patient with acute myeloid leukemia. Ann Hematol 1998; 76: 175–177.
- Monod M, Baudraz-Rosselet F, Ramelet AA, Frenk E. Direct mycological examination in dermatology: a comparison of dif-ferent methods. Dermatologica 1989; 179: 183–186.
- Riichel R, Schaffrinski M. Versatile fluorescent staining of fungi in clinical specimens using the optical brightener Blankophor-P. J Gun Microbiol 1999; 37: 2694–2696.